![Jinghai XU | Ph.D. | Merck & Co., Whitehouse Station | MSD | Scientific Knowledge Discovery | Research profile Jinghai XU | Ph.D. | Merck & Co., Whitehouse Station | MSD | Scientific Knowledge Discovery | Research profile](https://i1.rgstatic.net/ii/profile.image/272801009500168-1442052237421_Q512/Jinghai-Xu-3.jpg)
Jinghai XU | Ph.D. | Merck & Co., Whitehouse Station | MSD | Scientific Knowledge Discovery | Research profile
![Nanomaterials | Free Full-Text | Optimized Planar Microwave Antenna for Nitrogen Vacancy Center Based Sensing Applications Nanomaterials | Free Full-Text | Optimized Planar Microwave Antenna for Nitrogen Vacancy Center Based Sensing Applications](https://pub.mdpi-res.com/nanomaterials/nanomaterials-11-02108/article_deploy/html/images/nanomaterials-11-02108-g001.png?1629368176)
Nanomaterials | Free Full-Text | Optimized Planar Microwave Antenna for Nitrogen Vacancy Center Based Sensing Applications
![Kevin BATEMAN | Distinguished Scientist | PhD | Merck & Co., Whitehouse Station | MSD | Department of Pharmacokinetics, Pharmacodynamics & Drug Metabolism (PPDM) | Research profile Kevin BATEMAN | Distinguished Scientist | PhD | Merck & Co., Whitehouse Station | MSD | Department of Pharmacokinetics, Pharmacodynamics & Drug Metabolism (PPDM) | Research profile](https://i1.rgstatic.net/ii/profile.image/667943096557579-1536261452373_Q512/Kevin-Bateman-2.jpg)
Kevin BATEMAN | Distinguished Scientist | PhD | Merck & Co., Whitehouse Station | MSD | Department of Pharmacokinetics, Pharmacodynamics & Drug Metabolism (PPDM) | Research profile
![Diagnostics | Free Full-Text | Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy Diagnostics | Free Full-Text | Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy](https://pub.mdpi-res.com/diagnostics/diagnostics-12-02091/article_deploy/html/images/diagnostics-12-02091-g001.png?1661933155)
Diagnostics | Free Full-Text | Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy
Addressing unmet clinical needs – how Steve Xu became an engineer and what motivated him to commercialize his research | For Researchers | Springer Nature
State of the art energy conversion at the nanointerface: general discussion - Faraday Discussions (RSC Publishing)
![Hematopoietic Progenitor Kinase 1 in Tumor Immunology: A Medicinal Chemistry Perspective | Journal of Medicinal Chemistry Hematopoietic Progenitor Kinase 1 in Tumor Immunology: A Medicinal Chemistry Perspective | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c00172/asset/images/medium/jm2c00172_0025.gif)